However, other studies have revealed that high baseline S100A12 concentration is associated with higher disease activity and response to methotrexate (MTX) and anti-TNF therapy in patients with JIA including pJIA, ERA, oligoarticular and psoriatic arthritis [44]. This evidence concerns the gene S100A12 and juvenile idiopathic arthritis.